Discover
INAB
IN8bio, Inc.
1.19
2 x 1.02
2 x 1.77
bid
ask
-
0.01
1.25%
2 @ 04:00 PM
1.21 +0.02 (2.11%)
| Ytd | -49.36% | |
| 1y | -44.37% |
1.17
day range
1.24
0.88
52 week range
2.73
| Open | 1.21 | Prev Close | 1.20 | Low | 1.17 | High | 1.24 | Mkt Cap | 11.68M |
| Vol | 9.83K | Avg Vol | 56.04K | EPS | -1.62 | P/E | N/A | Forward P/E | -0.80 |
| Beta | -0.07 | Short Ratio | 0.51 | Inst. Own | 46.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.16 | 200-d Avg | 1.53 | 1yr Est | 4.75 |
| Income Statement | |||
| Operating Expenses | 4.93M | ||
| Research and Development Expense | 2.49M | ||
| Selling, General and Administrative Expense | 2.44M | ||
| Operating Income | -4.93M | ||
| Net Income | -4.78M | ||
| Net Income Common Stock | -4.78M | ||
| Net Income Common Stock (USD) | -4.78M | ||
| Consolidated Income | -4.78M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -4.78M | ||
| Earning Before Interest & Taxes (USD) | -4.78M | ||
| Weighted Average Shares | 19.47M | ||
| Weighted Average Shares Diluted | 19.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.96M | ||
| Cash and Equivalents (USD) | 17.96M | ||
| Investments | 176.00K | ||
| Investments Non-Current | 176.00K | ||
| Current Assets | 18.50M | ||
| Property, Plant & Equipment Net | 2.97M | ||
| Total Assets | 21.75M | ||
| Debt Current | 1.05M | ||
| Total Debt | 2.18M | ||
| Current Liabilities | 2.25M | ||
| Debt Non-Current | 1.13M | ||
| Total Liabilities | 3.38M | ||
| Accumulated Retained Earnings (Deficit) | -150.97M | ||
| Shareholders Equity | 18.36M | ||
| Shareholders Equity (USD) | 18.36M | ||
| Assets Non-Current | 3.25M | ||
| Total Debt (USD) | 2.18M | ||
| Liabilities Non-Current | 1.13M | ||
| Trade and Non-Trade Payables | 444.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 457.00K | ||
| Net Cash Flow from Financing | -51.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.03M | ||
| Capital Expenditure | -233.00K | ||
| Issuance (Purchase) of Equity Shares | 11.00K | ||
| Issuance (Repayment) of Debt Securities | -62.00K | ||
| Net Cash Flow from Investing | -233.00K | ||
| Net Cash Flow from Operations | -3.74M | ||
| Share Based Compensation | 352.00K | ||